Previous close | 42.51 |
Open | 42.48 |
Bid | 41.36 x 2900 |
Ask | 43.38 x 800 |
Day's range | 42.34 - 42.62 |
52-week range | 27.37 - 45.76 |
Volume | |
Avg. volume | 44,363 |
Market cap | 1.595B |
Beta (5Y monthly) | 0.61 |
PE ratio (TTM) | 34.80 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 10 Dec 2018 |
1y target est | N/A |
NEW YORK, April 15, 2024--Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., January 25, 2024--TARO PROVIDES RESULTS FOR DECEMBER 31, 2023